Centre for Blood Transplant and Cell Therapy [ 2017 - 2022 ]

Research Grant

Researchers: Prof Geoff Hill (Principal investigator) ,  A/Pr David Curtis ,  Prof Bruce Blazar ,  Prof David Gottlieb ,  Prof David Ritchie
View all 6 related researchers

Brief description Over 10,000 persons per year in Australia are diagnosed with a blood cancer, accounting for 11% of cancer deaths. Stem cell transplantation remains curative therapy for these diseases but is limited by cancer relapse and an immune-mediated process known as graft-versus-host disease (GVHD) which account for death of up to 50% of patients. This CRE will integrate centres from Australia and the USA to coordinate new treatments in transplant and cell therapy to improve blood cancer outcomes.

Funding Amount $AUD 2,533,851.36

Funding Scheme Centres of Research Excellence

Notes Centre of Research Excellence - Clinical